Captrust Financial Advisors Dexcom Inc Transaction History

Captrust Financial Advisors

$30.9 Billion
Q2 2024

A detailed history of Captrust Financial Advisors transactions in Dexcom Inc stock. As of the latest transaction made, Captrust Financial Advisors holds 22,029 shares of DXCM stock, worth $1.58 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

22,029

Previous 22,276 1.11%

Holding current value

$1.58 Million

Previous $3.09 Million 19.16%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $27,246 - $34,691	-247 Reduced 1.11%	22,029 $2.5 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $2.52 Million - $3.09 Million	-22,084 Reduced 49.78%	22,276 $3.09 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $511,897 - $841,928	6,781 Added 18.04%	44,360 $5.5 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $917,743 - $1.47 Million	10,664 Added 39.62%	37,579 $3.51 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $805,960 - $938,602	7,166 Added 36.29%	26,915 $3.46 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $37,024 - $43,759	-356 Reduced 1.77%	19,749 $2.29 Million
Q4 2022 Feb 15, 2023	BUY	$84.98 - $122.67 $92,713 - $133,832	1,091 Added 5.74%	20,105 $2.28 Million
Q3 2022 Nov 16, 2022	BUY	$76.35 - $94.18 $321,051 - $396,026	4,205 Added 28.39%	19,014 $1.53 Million
Q2 2022 Aug 23, 2022	SELL	$67.99 - $132.89 $106,540 - $208,238	-1,567 Reduced 9.57%	14,809 $1.1 Million
Q2 2022 Aug 16, 2022	BUY	$67.99 - $132.89 $828,322 - $1.62 Million	12,183 Added 290.56%	16,376 $1.22 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $94,268 - $130,460	1,002 Added 31.4%	4,193 $2.15 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $17,142 - $21,492	132 Added 4.32%	3,191 $1.71 Million
Q3 2021 Nov 16, 2021	SELL	$106.71 - $143.18 $87,502 - $117,407	-820 Reduced 21.14%	3,059 $1.67 Million
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $29,237 - $38,962	-361 Reduced 8.51%	3,879 $1.66 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $187,979 - $232,208	2,217 Added 109.59%	4,240 $1.52 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $17,394 - $23,303	223 Added 12.39%	2,023 $748,000
Q3 2020 Nov 17, 2020	BUY	$95.51 - $112.95 $20,725 - $24,510	217 Added 13.71%	1,800 $745,000
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $12,473 - $20,962	199 Added 14.38%	1,583 $634,000
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $2,437 - $3,857	-51 Reduced 3.55%	1,384 $353,000
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $49,949 - $78,143	1,364 Added 1921.13%	1,435 $315,000
Q2 2019 Aug 13, 2019	BUY	$27.84 - $38.92 $1,280 - $1,790	46 Added 184.0%	71 $11,000
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $278 - $384	25	25 $1,000

Others Institutions Holding DXCM

# of Institutions

1,112

Shares Held

365M

Call Options Held

4.1M

Put Options Held

3.65M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $27.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Dexcom Inc Transaction History